Cargando…
Bone marrow and plasma FGF‐23 in heart failure patients: novel insights into the heart–bone axis
AIMS: Fibroblast growth factor 23 (FGF‐23) is known to be elevated in patients with congestive heart failure (CHF). As FGF‐23 is expressed in the bone but can also be expressed in the myocardium, the origin of serum FGF‐23 in CHF remains unclear. It is also unclear if FGF‐23 expressed in the bone is...
Autores principales: | von Jeinsen, Beatrice, Sopova, Kateryna, Palapies, Lars, Leistner, David M., Fichtlscherer, Stephan, Seeger, Florian H., Honold, Jörg, Dimmeler, Stefanie, Aßmus, Birgit, Zeiher, Andreas M., Keller, Till |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487718/ https://www.ncbi.nlm.nih.gov/pubmed/30912310 http://dx.doi.org/10.1002/ehf2.12416 |
Ejemplares similares
-
Differential prognostic accuracy of right ventricular dysfunction, the Seattle heart failure model and the MAGGIC score in patients with severe mitral regurgitation undergoing the MitraClip® procedure
por: Heyl, S., et al.
Publicado: (2020) -
Post-myocardial infarction heart failure dysregulates the bone vascular niche
por: Hoffmann, Jedrzej, et al.
Publicado: (2021) -
Daily non‐invasive haemodynamic telemonitoring for efficacy evaluation of MitraClip® implantation in patients with advanced systolic heart failure
por: Herrmann, Ester, et al.
Publicado: (2018) -
Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model
por: Boeckel, Jes-Niels, et al.
Publicado: (2016) -
FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)